Compare Amphastar Pharmaceuticals Inc (AMPH) vs Digital Realty Trust, Inc. (DLR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Digital Realty Trust, Inc. — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while Digital Realty Trust, Inc. trades at $177.89 (market cap $66.75B). The key difference: Digital Realty Trust, Inc. is far larger — about 80.8× Amphastar Pharmaceuticals Inc's market cap, and Digital Realty Trust, Inc. pays a 2.7% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | DLR | |
|---|---|---|
Market Cap | $826.08M | $66.75B |
Sector | Health | Real Estate |
52-Week High | $30.81 | $203.91 |
52-Week Low | $16.87 | $147.93 |
Enterprise Value | $1.22B | $84.27B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Digital Realty Trust (DLR) trades at $180.41, up 0.6% on the day, with a bearish technical signal despite strong analyst consensus. The stock shows robust fundamentals with revenue growth to $6.11B in 2025 and net income margin of 21.73%, though valuation ratios like P/E of 47.85 appear elevated. Recent news highlights a $7.8B acquisition of Blackstone's data center stake, expanding its hyperscale portfolio amid AI-driven demand.
Outlook remains positive with a consensus price target of $218.77, implying 21% upside, supported by AI infrastructure expansion. Key risks include high debt levels, execution challenges from recent deals, and interest rate sensitivity. Institutional sentiment is bullish with 60% buy ratings, but technical weakness near support at $178 warrants caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Digital Realty Trust, Inc.
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →
